Alloplex’s Founder and CEO, Dr. Frank Borriello, will be speaking at the 3rd Gamma Delta T Therapies Summit on Thursday 28th July 2022 at 11 AM in a session titled “Reviewing the clinical safety and efficacy of gamma delta therapies” on the Response in Solid Tumors of Non-Engineered Autologous Multi-Cell Therapy.
Synopsis of Dr. Borriello’s presentation:
Our CSO, Dr. James Lederer, also presented at the pre-conference deep dive day on the 26th on the topic ‘Studying the Mechanisms of Action of Polyfunctional Gamma Delta T Cells’. By all reports, it’s an excellent meeting with great ideas circulating and lots to learn.
“Clearly Gamma T cells have a lot of promise as an anti-tumor therapy and we are glad to be part of the effort to assess this clinical activity”, Dr. Borriello commented.
Register here: https://gamma-delta-t-therapies.com/